Day-3 vs. Day-5 fresh embryo transfer

Putu Githa Garbhini; Anom Suardika; AAN Anantasika; IB Putra Adnyana; I Made Darmayasa; Nono Tondohusodo; Jaqueline Sudiman

JBRA Assist. Reprod. 2023;27(2):163-168
ORIGINAL ARTICLE
doi: 10.5935/1518-0557.20220027

Day-3 vs. Day-5 fresh embryo transfer

Putu Githa Garbhini¹, Anom Suardika^1,2, AAN Anantasika¹, IB Putra Adnyana^1,2, I Made Darmayasa^1,2, Nono Tondohusodo^1,2, Jaqueline Sudiman^2,3

¹Obstetrics and Gynaecology Department, School of Medicine, Udayana University, Denpasar- Bali, Indonesia
²Bali Royal Hospital, Royal IVF clinic, Denpasar-Bali, Indonesia
³Anatomy Department, School of Medicine, Udayana University, Denpasar-Bali, Indonesia

Received October 10, 2021
Accepted April 21, 2022

Corresponding author:
Jaqueline Sudiman
#Bali Royal Hospital
Royal IVF clinic
#Anatomy Department
Faculty of Medicine
Udayana University
Denpasar-Bali, Indonesia
E-mail:j_sudiman@yahoo.com
jaqueline@unud.ac.id

CONFLICTS OF INTEREST
None

ABSTRACT
Objective: Embryo transfer on day-5 has been associated with higher success rates, therefore our IVF clinics started to extend embryo culture until blastocyst stage. This study aimed to compare the success rates of day-3 vs. day-5 embryo transfers.
Methods: We had 266 patients included, all having undergone ICSI, with 221 patients having undergone day-3 embryo transfers, and 45 patients having undergone day-5 embryo transfers. Patients with more than five good quality embryos on day-3 were chosen to prolong the culture of embryos into day-5.
Results: There were no significant differences in patient characteristics, including baseline LH, FSH, Prolactin and Estradiol hormone levels. In addition, there were also no significant differences in rFSH total dosage and duration of stimulation day. Final estradiol levels, number of follicles, retrieved oocytes, matured oocytes, fertilized oocytes and number of embryos were significantly higher in day-5 compared to day-3 embryo transfer groups. Number of embryos transferred on day-3, were significantly higher compared to day-5. Neither group showed any significant differences in clinical pregnancy, implantation, multiple pregnancy or living birth rates. There were no differences in birth weights and lengths, head circumstances and Apgar Scores between both groups either in singleton or twin group.
Conclusions: Transferring embryos at day-3 may provide the same benefits as day-5 embryo transfers to patients. However, more embryos were required to be transferred to achieve these comparable results.

Keywords: day-3 embryo transfer, day-5 embryo transfer, implantation rate, live birth rate, pregnancy rate

INTRODUCTION
Twelve to fifteen percent of reproductive couples suffer from infertility. Assisted reproductive technology (ART) is one of the advanced treatment options that can treat infertility problems. However, the success rate of ART has not improved significantly over the last 10 years. Pregnancy rate following ART is approximately 30-40%, with living birth rates per embryo transfer cycle of approximately 20-30% (ANZARD, 2018; De Geyter, 2019).
Several options have been proposed to increase the success rate of ART, such as prolonging embryo culture. Human embryos are usually transferred either on day-3 (cleavage stage) or day-5 (blastocyst stage). Prolonging embryo culture may increase the success rate of ART (Levron et al., 2002; Gardner et al., 1998; Schwärzler et al., 2004). The reasons behind this new strategy are that embryos implant in the uterus at blastocyst stage naturally, and extended embryo culture until day-5 could lead to embryo selection that has demonstrated good outcomes (Gardner & Lane, 2003). Furthermore, embryos at blastocyst stage have their own genomic control and have already passed the maternal to zygotic transition (Johnson et al., 2007; Braude et al., 1988). Extended embryo culture until day-5 could also decrease the number of embryos being transferred, therefore reducing the incidence of multiple pregnancies (Gardner et al., 2000; 2004). On the other hand, critics on extended embryo culture have reported an increase in embryo transfer cancellations due to a failure in embryos developing into blastocysts on the day of transfer, a failure to have extra embryos available to be frozen, the requirement of an excellent culture system, an increase in monozygotic twinning, and altered sex ratio in births (Johnson et al., 2007; Ménézo et al., 1999). Some studies have also reported that there were no differences in the success rates of IVF between embryo transfers on day 3 and embryo transfers on day 5 (Bungum et al., 2003; Hatırnaz & Kanat Pektaş, 2017; Coskun et al., 2000).
Due to the difficulty in cultivating embryos for a period of five days, it became common practice to transfer embryos at cleavage stage on days two or three. Until 2018, our IVF clinic only transferred embryos on day three; however, we sought to determine if extended embryo culture to day five could increase the success rate in our patients. Therefore, the aim of this study was to investigate pregnancy outcomes following day-3 and day-5 embryo transfers.

MATERIALS AND METHODS
We conducted this retrospective cross-sectional study at the Royal IVF clinic, Bali Royal Hospital, Indonesia. We used secondary data from medical records of all patients who matched our criteria and had undergone intracytoplasmic sperm injection (ICSI) treatment between 2016 and 2019. This study was approved by the local ethics committee from Udayana University (667/UN14.2.2.VII.14/LT/2020).
We collected data from 266 patients, under the age of 40 years, submitted to ICSI. The inclusion criteria selected patients which were less than 40 years of age, normal responders with AFC ≥5 follicles, and had undergone a complete IVF program for which embryo transfers were performed on day three or day five.
There were 221 patients in the day-3 embryo transfer group and 45 patients in the day-5 embryo transfer group. All patients were administrated GnRH-antagonist protocols. Briefly, recombinant follicle-stimulating hormone (Gonal F, Serono, Switzerland) was used on day three of the menstrual cycle. The dosage of FSH was adjusted based on ovarian response and was assessed by transvaginal ultrasound and serum estradiol level. If two or more follicles reached a mean diameter ≥ 18 mm, the patients were injected with 10,000 IU of recombinant hCG (Serono, Switzerland). Ovum pick up was performed transvaginally, 34-38 hours after hCG injection. Two hours after oocyte retrieval the oocytes were denuded, and all matured oocytes were inseminated by ICSI. All fertilized oocytes were cultured for three days in culture media (G1, Vitrolife, Gothenburg, Sweden), or continued until day five using blastocyst media (G2, Vitrolife, Gothenburg, Sweden). In order to avoid the cancellation of embryo transfers, the clinic’s policy was to only choose patients showing at least five high-quality embryos on day three to extend embryo culture until day five. Embryos on day three were classified based on the grading by Kamardi et al. (2021). Grade one embryos were defined as 4-6 cells on day two, eight or more cells on day three, equal, fragmentation <10%, and no multinucleated blastomeres; grade-2 embryos were defined as 2-3 cells on day two, 6-7 cells on day three, equal or less equal, 10-20% fragmentation, and no multinucleated blastomeres; grade-3 embryos were defined as 0-2 cells on day two, 1-5 cells on day three, unequal, fragmentation >25%, with or without multinucleated blastomeres. Grade-1 and -2 embryos were considered top-quality embryos. Blastocysts were graded based on the modified grading by Richardson et al. (2015), which is defined by the size of the blastocele cavity (early, full, expanded); the size of inner cell mass; and trophectoderm layer distribution. Grade-A and - B blastocysts on day five were considered top-quality embryos. Early blastocysts or blastocysts with no inner cell mass were included among grade-C blastocysts. One to three embryos were transferred on day three or day five of embryo transfers.
The first parameters that we evaluated in this study were patient characteristics including age, BMI, number of cycles, type and duration of infertility, and baseline hormone levels (FSH, LH, prolactin and estradiol).
The second set of parameters that we measured were ovarian responses, including total rFSH dosage used, the length of ovulation induction, endometrial thickness on the hCG day, level of estradiol upon last evaluation, number of follicles, number of oocytes retrieved, number of matured oocytes, number of oocytes fertilized, number of embryos developed, and number of embryos transferred.
The third set of parameters that we measured were: chemical pregnancy (level of hCG ≥50 mIU/mL), clinical pregnancy (gestational sac seen on USG), the implantation rate (the ratio of gestational sac/number of embryos transferred), live birth rate (number of babies delivered/number of gestational sac), miscarriage and ectopic pregnancy rates.
The fourth set of parameters that we measured were neonatal outcomes, including birth weight, birth length, head circumstance, Apgar score and sex (table 4). 102 babies were born from day-3 embryo transfers, we collected data from 96 neonates born in our hospital. Out of 96 babies, 70 were singletons and 26 were twins. From 23 babies born from day-5 embryo transfers, we collected data from 22 neonates. Out of 22 babies, 16 were singletons and 6 were twins.
The data were expressed as mean ± SD or number (percentage) and analyzed using the SPSS version 25.0. The data were analyzed using the independent t-test from difference subjects. Due to small samples in the day-5 compared to the day-3 embryo transfer groups, we used a non-parametric test (Mann-Whitney test) to compare the means/medians. Proportions were compared using the Chi-square test. All statistical significance was set as p<0.05.

RESULTS

Baseline Characteristic
Table 1 depicts baseline characteristics of IVF embryo transfer patients from days -3 and -5 groups. There were no differences in age, BMI, infertility type, number of cycles, type of infertility and duration of infertility. There were no significant differences in baseline FSH, LH, Prolactin and Estradiol levels in both groups.

Table 1. Baseline characteristics for day-3 vs. day-5 embryo transfers.

Ovarian stimulation parameters and IVF results
Table 2 shows that the two groups were comparable with regards to rFSH dose and duration of stimulation. There were significant differences in final estradiol level, number of follicles, number of retrieved oocytes, number of mature oocytes, and number of fertilized oocytes, number of high-quality embryos on day three in the day-5 embryo transfer group, compared to the day-3 embryo transfer group (p<0.01). There were significantly higher numbers of embryos transferred in the day three compared to the day-5 embryo transfer groups.

Table 2. Ovarian response and embryo development for day-3 vs. day-5 embryo transfers.

Pregnancy outcomes
Looking at pregnancy outcomes, there were no statistically significant differences in chemical pregnancy, clinical pregnancy, implantation, live delivery or multiple pregnancy rates between the groups (Table 3). Two out of 93 pregnant patients in the day three embryo transfer group had miscarriages and three had ectopic pregnancies. We only found one patient in the day-5 embryo transfer group who suffered from miscarriage.

Table 3. ICSI outcomes for day-3 vs. day-5 embryo transfers.

Table 4. Neonatal outcomes for day-3 vs. the day-5 embryo transfers.

Neonatal Outcomes
There were no significant differences in birth weights, birth lengths, head circumstances infants between day-3 and day-5 embryo transfers in either the singletons or the twins group. Only one baby in the day-3 transfer group had lower Apgar score. Day-3 and day-5 embryo transfers had almost the same sex ratios.

DISCUSSION
IVF success depends on endometrium receptivity and embryo quality. In recent years, advances in embryo culture systems and media development have encouraged clinics to extend embryo transfer until the blastocyst stage. The advantages of blastocyst transfer (day five to six) compared to cleavage stage transfer (day two to three) are still controversial. Some reports suggest that blastocyst transfer is more favorable than cleavage transfer (Levron et al., 2002; Gardner et al., 1998; Schwärzler et al., 2004; Papanikolaou et al., 2005; Karaki et al., 2002). However, other reports indicate that there are no differences in success rates between blastocyst and cleavage transfers (Bungum et al., 2003; Hatırnaz & Kanat Pektaş, 2017; Coskun et al., 2000; Alfaraj et al., 2017). Results of Cochrane studies, that examine day-3 compared to day-5 embryo transfer, are also variable and inconsistent (Glujovsky et al., 2012; 2016). A Cochrane study that included 27 randomized controlled trials suggested that blastocyst transfer may increase pregnancy rates between 3-10%, and live birth rates between 3-13%, compared to cleavage-stage transfers (Glujovsky et al., 2016). However, cumulative clinical pregnancy rates from cleavage stage, derived from fresh and frozen cycles, resulted in the same or slightly better results compared to blastocyst transfers (Glujovsky et al., 2012; 2016). This may be due to an increase in embryo cancellation and decrease in the number of embryos frozen in the blastocyst group. In our data, to avoid embryo cancellation, we only chose patients with more than five good quality embryos on day three, to extend embryo culture to blastocyst stage and therefore not have embryo transfer cancellation data to report. A prospective randomized controlled trial also used the same strategy as us, in which poor responders or low number of high-quality embryos on day three had embryo transfer on days two or three (Hatırnaz & Kanat Pektaş, 2017). They found no statistically significant differences in implantation, clinical pregnancies, miscarriages, perinatal death, and live birth rates between days -3 and -5 transfer groups. Similar results were found in this present study, where there were no significant differences in pregnancies, implantation, live birth, and multiple pregnancies between the groups. However, to achieve these comparable results, more embryos were required to be transferred in the day-3 group compared to day-5 embryo transfer groups. A study by Schwärzler et al. (2004), using patients with at least one previous implantation failure with higher follicle number, found that day-5 transfers were significantly superior in terms of pregnancy and live birth rates when compared to day three transfers. They also found more multiple gestations among patients following day-5 transfers, even though the number of embryos transferred was similar to that of day-3 transfers. This was probably due to a lower rate of aneuploidy at blastocyst stage compared to the cleavage stage (Staessen et al., 2004).
Culturing embryos until the blastocyst stage also requires an excellent culture system. In this study, around 73% of cleavage embryos on day three developed into blastocyst stage on day five. From 73% blastocyst rate, around 34.3% became grade A and grade B blastocysts. The number of blastocysts derived from cleavage embryos is different from one unit to another and depends on the quality of oocytes, sperm, and underlying infertility disease. In general, the blastocyst rate from cleavage stage ranges from 28% to 60.3% (Glujovsky et al., 2012; 2016). A prospective randomized study indicated that single blastocyst transfers from young-age women with excellent quality had significantly higher pregnancy rates compared to single embryo cultures on day three (40.8% and 25.6%, respectively). However, this number drops from 40.8% to 26.2% if there is only one moderate quality blastocyst available on the day of embryo transfer (Zech et al., 2007). It appears that blastocyst transfers are more favorable if it is aimed at transferring only a single embryo.
Looking at miscarriage and ectopic pregnancy rates, there were no significant differences in both groups; however, our sample was too small to be statistically analyzed. Meta-analysis studies have shown no significant differences in miscarriage rates (Glujovsky et al., 2012; 2016). A study from Schwärzler et al. (2004) also reported that there were no differences in genetic birth defects between the groups.
This present study shows that there are no significant differences in birth weights between day-3 vs. day-5 embryo transfer groups. Similar results have been reported, that there were no differences in mean birth weights in singleton groups between fresh embryo transfer on day-3 and day-5 groups (Rahil et al., 2018). However, it has been shown that frozen embryo transfer on day five was associated with a lower birthweight compared to frozen embryo transfer on day three (De Vos et al., 2018). On the contrary, another study with large samples has shown that there was a significantly higher birth weight after good- quality blastocyst transfer on day five or day six compared to day-3 embryo transfers (Wang et al., 2021). Multiple births are the complication associated with multiple embryos transferred, associated with adverse health outcomes, including low birth weight. In this present study, the birth weights in the twins’ group in either day-3 or day-5 groups are significantly lower compared to singleton groups; however, there were no genetic abnormalities in the twins’ groups. Only one baby had Apgar score below 7.
To conclude, transferring embryos on day three may provide the same benefits as day-5 embryo transfers to patients; however, more embryos may require to be transferred. Despite this, our results also do not support the notion that embryos from all patients showed an equal implantation potential on days 3 or 5. Larger data samples are required for future studies, as well as reports of total pregnancy rates, which include frozen embryo transfers.

Acknowledgment
The authors would like to thank the Bali Royal Hospital (BROS) for providing the data, and Mr. G. K. Heinemann for checking for grammatical errors.

Financial Support
None.

Ethical StandardsThe authors assert that all procedures contributing to this study complied with ethical standards of the relevant national and institutional committees on human experimentation, and with the Helsinki Declaration of 1975, and revised in 2008. This study was approved by the local ethics committee from Udayana University (667/UN14.2.2.VII.14/LT/2020).

REFERENCES
Alfaraj S, Alzaher F, Alshwaiaer S, Ahmed A. Pregnancy outcome of day three versus day five embryo transfer: A retrospective analysis. Asian Pac J Reprod. 2017;6:89-92. DOI: 10.12980/apjr.6.20170208

ANZARD - Australian and New Zealand Assisted Reproduction Database. Assisted Reproduction in Australia and New Zealand 2018. Available at: https://npesu.unsw.edu.au/surveillance/assisted-reproductive-technology-australia-and-new-zealand-2018

Braude P, Bolton V, Moore S. Human gene expression first occurs between the four- and eight-cell stages of preimplantation development. Nature. 1988;332:459-61. PMID: 3352746 DOI: 10.1038/332459a0 Medline

Bungum M, Bungum L, Humaidan P, Yding Andersen C. Day 3 versus day 5 embryo transfer: a prospective randomized study. Reprod Biomed Online. 2003;7:98-104. PMID: 12930586 DOI: 10.1016/S1472-6483(10)61736-1 Medline

Coskun S, Hollanders J, Al-Hassan S, Al-Sufyan H, Al-Mayman H, Jaroudi K. Day 5 versus day 3 embryo transfer: a controlled randomized trial. Hum Reprod. 2000;15:1947-52. PMID: 10966992 DOI: 10.1093/humrep/15.9.1947 Medline

De Geyter C. European pregnancy rates from IVF and ICSI ‘appear to have reached a peak’. In: ESHRE Meeting 2019. Available at: https://www.eshre.eu/Annual-Meeting/Vienna-2019/Media/2019-Press-releases/EIM

De Vos A, Santos-Ribeiro S, Van Landuyt L, Van de Velde H, Tournaye H, Verheyen G. Birthweight of singletons born after cleavage-stage or blastocyst transfer in fresh and warming cycles. Hum Reprod. 2018;33:196-201. PMID: 29206936 DOI: 10.1093/humrep/dex361 Medline

Gardner DK, Schoolcraft WB, Wagley L, Schlenker T, Stevens J, Hesla J. A prospective randomized trial of blastocyst culture and transfer in in-vitro fertilization. Hum Reprod. 1998;13:3434-40. PMID: 9886530 DOI: 10.1093/humrep/13.12.3434 Medline

Gardner DK, Lane M, Stevens J, Schlenker T, Schoolcraft WB. Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer. Fertil Steril. 2000;73:1155-8. PMID: 10856474 DOI: 10.1016/S0015-0282(00)00518-5 Medline

Gardner DK, Lane M. Blastocyst transfer. Clin Obstet Gynecol. 2003;46:231-8. PMID: 12808377 DOI: 10.1097/00003081-200306000-00005 Medline

Gardner DK, Surrey E, Minjarez D, Leitz A, Stevens J, Schoolcraft WB. Single blastocyst transfer: a prospective randomized trial. Fertil Steril. 2004;81:551-5. PMID: 15037401 DOI: 10.1016/j.fertnstert.2003.07.023 Medline

Glujovsky D, Blake D, Farquhar C, Bardach A. Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology. Cochrane Database Syst Rev. 2012;7:CD002118. PMID: 22786480 DOI: 10.1002/14651858.CD002118.pub4 Medline